Expanded Access Protocol to Provide Lumasiran to Patients With Primary Hyperoxaluria Type 1
Clinical trial NCT04125472 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04125472
- Sponsor
- Alnylam Pharmaceuticals
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.